Ty3 is a 5.4-kb, retroviruslike element of the yeast Saccharomyces cerevisiae (49) . The two open reading frames of Ty3, GAG3 and POL3, are analogous to the retroviral gag and pol genes. They encode the structural proteins capsid (CA) and nucleocapsid (NC) and the enzymes protease (PR), reverse transcriptase (RT), and integrase (IN), respectively (29) (30) (31) 35) . These proteins, associated with genomic RNA, assemble into viruslike particles (VLPs), and polyprotein maturation and reverse transcription ensue. Ty3 differs, however, from retroviruses in that it inserts specifically into the transcription initiation site of genes transcribed by RNA polymerase III (8). In addition, Ty3 IN has extended, weakly conserved domains amino and carboxyl terminal to the central, conserved domain that contains the zinc-binding motif and catalytic D-D-(35)E triad. These terminal domains were previously examined by molecular genetics in order to understand their role(s) in functions unique to Ty3. Deletion (37) and alanine-scanning mutagenesis (47) revealed pleiotropic effects of mutations in the nonconserved IN domains on Ty3 replication, including effects on RT and IN protein processing and stability, DNA content of the VLP, 3Ј end processing, and nuclear entry. Mutations that eliminate large portions of the human immunodeficiency virus type 1 (HIV-1) IN-coding sequence and point mutations in the zinc finger and catalytic core region (F185Y) result in lower amounts of DNA circles in infected cells (17, 18, 45) . More recently, these mutations and a small carboxyl-terminal deletion of IN were shown to specifically reduce the amount of early reverse transcription intermediates that could be used as templates in a PCR to amplify the R-U5 region (58). In another study, nine conserved S, T, Y, K, and R residues of IN were mutated to test for contributions to reverse transcription. R186, which maps near the nuclear localization sequence of HIV-1 IN (4), was required for wild-type amounts of an early replication intermediate as measured by PCR (53). Consistent with these effects of IN structure on RT function, HIV-1 IN and RT have been shown to interact (58). Recently, similar findings have been reported for the effects of mutations in Moloney murine leukemia virus IN on cDNA production (40), suggesting that the contribution of IN to reverse transcription may be a more general phenomenon. Nevertheless, the exact contribution of IN to reverse transcription is not yet understood at the molecular level.
Ty3 is a 5.4-kb, retroviruslike element of the yeast Saccharomyces cerevisiae (49) . The two open reading frames of Ty3, GAG3 and POL3, are analogous to the retroviral gag and pol genes. They encode the structural proteins capsid (CA) and nucleocapsid (NC) and the enzymes protease (PR), reverse transcriptase (RT), and integrase (IN), respectively (29) (30) (31) 35) . These proteins, associated with genomic RNA, assemble into viruslike particles (VLPs), and polyprotein maturation and reverse transcription ensue. Ty3 differs, however, from retroviruses in that it inserts specifically into the transcription initiation site of genes transcribed by RNA polymerase III (8) . In addition, Ty3 IN has extended, weakly conserved domains amino and carboxyl terminal to the central, conserved domain that contains the zinc-binding motif and catalytic D-D-(35)E triad. These terminal domains were previously examined by molecular genetics in order to understand their role(s) in functions unique to Ty3. Deletion (37) and alanine-scanning mutagenesis (47) revealed pleiotropic effects of mutations in the nonconserved IN domains on Ty3 replication, including effects on RT and IN protein processing and stability, DNA content of the VLP, 3Ј end processing, and nuclear entry. Mutations that eliminate large portions of the human immunodeficiency virus type 1 (HIV-1) IN-coding sequence and point mutations in the zinc finger and catalytic core region (F185Y) result in lower amounts of DNA circles in infected cells (17, 18, 45) . More recently, these mutations and a small carboxyl-terminal deletion of IN were shown to specifically reduce the amount of early reverse transcription intermediates that could be used as templates in a PCR to amplify the R-U5 region (58) . In another study, nine conserved S, T, Y, K, and R residues of IN were mutated to test for contributions to reverse transcription. R186, which maps near the nuclear localization sequence of HIV-1 IN (4), was required for wild-type amounts of an early replication intermediate as measured by PCR (53) . Consistent with these effects of IN structure on RT function, HIV-1 IN and RT have been shown to interact (58) . Recently, similar findings have been reported for the effects of mutations in Moloney murine leukemia virus IN on cDNA production (40) , suggesting that the contribution of IN to reverse transcription may be a more general phenomenon. Nevertheless, the exact contribution of IN to reverse transcription is not yet understood at the molecular level.
Models to explain the contribution of Ty3 IN to extrachromosomal Ty3 DNA would be compatible with effects at several different points. These include roles in initiation complex assembly, minus-strand or plus-strand transfers, elongation, and stabilization of the extrachromosomal DNA. In replication, the IN domain could function in cis to the RT domain, for example as part of an RT-IN fusion, or in trans, for example by folding RT. Precedents for these models can be found among the retroviruses. In the case of avian leukosis-sarcoma, in the ␣-␤ form of RT comprised of pol-RNaseH and pol-RNaseH-IN subunits, IN acts in cis with the pol-RNaseH domain (10, 25, 27, 33, 50) . In the case of HIV, which has a heterodimeric RT composed of pol-RNaseH and pol subunits (44) , IN contributes to reverse transcription (41, 45, 53, 58) . The 55-kDa re-combinant form of the Ty3 RT is active on a synthetic DNA and RNA templates (48) and on a Ty3-like template with Ty3 NC and tRNA iMet primer for minus-strand, strong-stop DNA synthesis in vitro (11) . Nonetheless, this does not exclude the possibility that the major replication-competent form of Ty3 RT is an ␣-␤-type heterodimer similar to avian leukosis-sarcoma (55) . Ty3 VLPs do contain a 115-kDa RT-IN fusion protein, although in smaller amounts than the 55-kDa RT or the 61-kDa IN (31, 35) .
The present study was undertaken to further define the role of Ty3 IN in reverse transcription in vivo. Investigation of the phenotypes of cDNA-deficient mutants showed that they were deficient in early replication intermediates. CA-IN and CA-RT-IN fusion proteins were supplied in trans in order to test the contribution of an independent IN domain to reverse transcription. IN supplied via a CA-RT-IN fusion conferred lowlevel cDNA synthesis in the mutants; however, IN contributed as a CA-IN fusion did not. These results are consistent with a role for the IN domain in close association with the RT domain at the point of reverse transcription.
MATERIALS AND METHODS
Strains and culture conditions. Escherichia coli and S. cerevisiae strains were cultured and transformed using standard methodology (1) . Bacterial strains were cultured in 2ϫ yeast extract-tryptone medium or Luria broth medium containing 100 g of ampicillin per ml. Yeast strains were cultured in synthetic complete medium, containing glucose (SD) or galactose (SG) as the carbon source and lacking the appropriate amino acids, as indicated for each experiment. S. cerevisiae strain AGY-9 (MATa ura3-52 his4-539 lys2-801 trp1-⌬63 leu2-⌬1 spt3) (a gift from J. D. Boeke, The Johns Hopkins University) was transformed with plasmids expressing wild-type or IN-mutant Ty3 and used for production of VLPs for Southern analysis of minus-strand, strong-stop DNA, Northern analyses of tRNA iMet and Ty3 RNA dimers, and for tRNA iMet primer tagging experiments. This strain does not express Ty1, due to a mutation in the spt3 gene (57 (1) . Plasmids are described in Table 1 . Oligonucleotides used in the mutagenesis are described in Table 2 . The plasmid pEGTy3-1 (30) and mutant derivatives thereof (37, 47) contain the GAL1-10 upstream activator sequence in place of the Ty3 promoter. In addition, pEGTy3-1 contains the 2m sequence for maintenance at high copy number in S. cerevisiae and the yeast selectable marker URA3. The target plasmid pCH2bo19V (34) , which was used in the transposition assays, contains the ARS1 and CEN4 sequences for maintenance at low copy number in S. cerevisiae, the yeast selectable marker HIS3, and the divergent tRNA gene Ty3 transposition target.
PTM843 (previously referred to as pTM45) (46), a low-copy-number, TRP1-marked plasmid that expresses Ty3-1 using the GAL1-10 upstream activation sequence, was modified by oligonucleotide mutagenesis using oligonucleotides 647 and 648, respectively, to contain SalI restriction sites at the downstream ends of the coding regions for CA and RT. The modified plasmid was digested with SalI, and the fragments were resolved by agarose gel electrophoresis. The purified plasmid backbone was religated, producing a fusion of the CA-and INcoding sequences contained in a 3,037-bp coding region. The XhoI fragment containing the CA-and IN-coding sequences was inserted into pHN1889, an ARS1/ CEN4, TRP1-marked vector containing the (galactose-regulated) long terminal repeat (LTR) from pEGTy3-1 (unpublished results), at the single XhoI site in the LTR to form plasmid pHN2068. Plasmid pCG90 (23), pSP64 with a yeast tRNA iMet insertion, was used to produce tRNA iMet by in vitro transcription. The expression cassette for CA-RT-IN was constructed from pEGTy3-1 in several steps. First, a Psp14601 site was introduced at the downstream end of the CA-coding region by amplifying a fragment from nucleotides (nt) 115 to 1114 by PCR with an upstream primer positioned to include the BamHI site just upstream of the Ty3 and a downstream primer to introduce the Psp14601 site (oligonucleotides 810 and 811, respectively). A fragment containing nt 2006 to 2350 of the RT-coding region with an upstream Psp14601 and downstream KpnI sites was also amplified by PCR with appropriate primers (oligonucleotides 812 and 813). PCR fragments were ligated into pGEM-T Easy Vector (Promega). The BamHI-Psp14601 and Psp14601-KpnI fragments were then transferred into a vector backbone prepared from pEGTy3-1 by cleavage with BamHI and KpnI in a three-fragment ligation. This plasmid was designated pNB2091. In order to express the fusion from a low-copy-number plasmid, the internal XhoI fragment of pNB2091 was isolated and cloned into the XhoI site of pHN1889, as described above for the CA-IN fusion. This construct, pNB2092, was used to express the fusion protein under galactose regulation in the presence of the various mutant Ty3 elements.
The plasmid to express CA-RT-IN(cat Ϫ ) (Ty3 IN D225E, E261D catalytic site mutant) (48) was created through the same series of steps as for pNB2091, except that pJK784, which is the same as pEGTy3-1 except that it has the cat Ϫ mutation, was used as the backbone fragment (the region encoding the IN catalytic site was part of the DNA contributed from this plasmid). The resulting plasmid was pNB2093. The XhoI fragment containing one split LTR and the internal CA-RT-IN-coding region was cloned into pHN1889 to create pNB2094, a low-copynumber, TRP1-marked plasmid. This plasmid was used to express CA-RT-IN (cat Ϫ ) under galactose regulation in the presence of various mutant Ty3 elements.
VLP preparation. One-liter cultures of AGY-9 cells transformed with pEGTy3-1 or derivatives of the plasmid carrying Ty3 elements with mutations in the IN-coding region were grown to late log or stationary phase (A 600 , Ϸ1.3 to 3.4) in SG medium for 2 days to induce Ty3 expression. A mock VLP preparation was made with AGY-9 cells lacking the expression plasmid. VLPs were partially iMet . Southern analysis of minus-strand, strong-stop DNA. Nucleic acid was isolated from sucrose step gradients containing wild-type or IN-mutant VLPs, as described above, and the DNA concentration was measured by fluorometry using a TKO 100 DNA fluorometer (Hoefer Scientific Instruments). Approximately 1.5 ml of the VLP-containing sucrose fraction from 1 liter of yeast cells was used for DNA extraction. The amount of DNA recovered from each VLP preparation varied, with the yield from extracts of wild-type Ty3-expressing cells estimated to be Ϸ1 g and the yield from those expressing IN mutants estimated to be Ϸ50 to 600 ng. VLP DNA was treated with 2 g of RNase A, extracted with phenolchloroform-isoamyl alcohol (25:24:1), and precipitated with ethanol and 0.3 M sodium acetate in the presence of 5 g of carrier DNA. The DNA was fractionated on a sequencing-style gel and blotted and visualized essentially as described previously for Ty3 cDNA ends analysis (37) , except for the 32 P-5Ј-end-labeled oligonucleotide (oligonucleotide 210).
In vitro tRNA iMet primer tagging. Primer tagging experiments were performed using a method adapted from studies of tRNA incorporation in retroviruses (56) . The reaction products were resuspended in formamide gel loading buffer (Ambion), heated to 90°C for 2 min, and separated on an 6% polyacrylamide gel containing 7 M urea. The gel was fixed in 10% acetic acid and 5% methanol, dried, and exposed to a phosphorimager screen.
Northern analysis of Ty3 RNA dimers. For analysis of wild-type genomic Ty3 RNA, RNA was isolated from a VLP fraction containing 460 g of protein, extracted twice with phenol-chloroform-isoamyl alcohol (25:24:1), and precipitated with ethanol and 0.3 M sodium acetate in the presence of 10 g of glycogen. The RNA was resuspended in 100 l of R buffer (10 mM Tris [pH 7.5], 1 mM EDTA, 1% SDS, 50 mM NaCl) (2, 22) at a total nucleic acid concentration of 0.14 g/l. Nine samples of 9 l each (Ϸ1.3 g) were heated for 10 min at the temperatures indicated in Fig. 4A , and 1 l of 10ϫ native agarose gel loading buffer (40% sucrose, 0.17% bromophenol blue, 0.17% xylene cyanol) was added to each sample. The RNA was separated under native conditions (2, 22) on a 1% agarose gel in 1ϫ Tris-borate-EDTA at 5 V/cm and transferred onto GeneScreen Plus in 20ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate, pH 7.0), using a PosiBlot pressure blotter (Stratagene). RNA was immobilized by UV cross-linking and subjected to Northern analysis (9), with a probe specific for the internal (non-LTR) domain of Ty3. The probe was produced by BglII digestion of the Ty3-coding sequence and labeled with 50 Ci of [␣-
32 P]dATP (3,000 Ci/mmol; NEN) with the MegaPrime random primer DNA labeling system (Amersham). Hybridization was with 2 ϫ 10 6 cpm of 5Ј-end-labeled probe in Northern hybridization buffer (9) at 42°C for 16 h. The blot was washed and exposed to a phosphorimager screen.
For analysis of RNA dimers in VLPs from cells expressing IN mutants, RNA was isolated from fractions of wild-type or IN-mutant VLPs containing 20 g of protein, as described above. Assuming a recovery similar to the one in the above experiment, approximately 0.6 g of total nucleic acid was recovered from each 20-g VLP sample. The RNA was resuspended in 18 l of R buffer and 2 l of 10ϫ native agarose gel loading buffer. About 0.2 g of RNA in 8 l was separated under native conditions on a 1% agarose gel at 2 V/cm and subjected to Northern analysis with a Ty3-specific probe as described above.
Northern analysis of tRNA iMet . VLP RNA was isolated from an amount of the VLP fraction containing 20 g of protein from cells expressing wild-type or IN-mutant Ty3. RNA was extracted and precipitated, as described for Northern analysis of Ty3 RNA. The RNA was resuspended in formamide gel loading buffer (Ambion), heated to 90°C for 2 min, and separated on an 8% polyacrylamide gel containing 7 M urea. Three nanograms of in vitro-transcribed tRNA iMet (see below) was used as a size marker. The RNA was transferred onto a charged nylon membrane (GeneScreen Plus; NEN) in 1ϫ Tris-borate-EDTA as described above for minus-strand, strong-stop DNA analysis and immobilized by UV cross-linking. The blot was subjected to Northern analysis using a 32 P-5Ј-end-labeled oligonucleotide (oligonucleotide 83) specific for tRNA iMet . Hybridization and phosphorimaging conditions were the same as for Northern analysis of Ty3 RNA.
To generate a size control for Northern analysis of the tRNA iMet primer, the MEGAscript T7 transcription system (Ambion) was used to transcribe tRNA iMet in vitro. Plasmid pCG90 was used to generate the transcription template by digestion with BstNI. The transcription reaction was performed essentially as described by the manufacturer. tRNA iMet was resuspended in 50 l of RNase-free water and purified over a G-50 column to remove unincorporated nucleotides.
Whole-cell extraction of proteins. For immunoblot analysis of NCp9 protein from whole-cell extracts, 10-ml cultures of yTM443 cells transformed with pEGTy3-1 carrying a wild-type Ty3 or with derivatives of the plasmid carrying IN-mutant Ty3 were grown to an A 600 of Ϸ1.0 in SG medium. Cells were pelleted and suspended in 600 l of whole-cell protein extraction buffer A (0.1 mM EDTA, 25 mM HEPES [pH 7.5], 50 mM KCl, 5 mM MgCl 2 , 10% glycerol), containing 1 g of leupeptin per ml, 1 g of pepstatin A per ml, and 1 mM phenylmethylsulfonyl fluoride. For analysis of proteins in trans-complementation assays, 10-ml cultures of yTM443 cells transformed with plasmids expressing wild-type or IN-mutant Ty3 and with either pHN1889 (vector control), pHN2068
were grown in SG medium, harvested, and suspended in 400 l of whole-cell protein extraction buffer A, as described above. Cells were lysed by five cycles of vortexing with glass beads at maximum speed for 15 s and plunging into ice for 15 s. The extract was centrifuged in an Eppendorf microcentrifuge (Brinkmann), and the supernatant was transferred to a new tube. Protein content of the extracts was determined by the Bradford assay (5).
Immunoblot analysis. Proteins from whole-cell extracts were fractionated by SDS-10% polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (Hybond ECL; Amersham) using a semidry transfer apparatus (BioRad). Blots were blocked in 1% nonfat milk-TBST (100 mM Tris [pH 7.5], 150 mM NaCl, 0.2% Tween 20) and incubated with rabbit immunoglobulin G (IgG)-purified antibodies to NCp9 (1: 5,000), CA (1:2,500) (46), or IN (1:2,500) (46) . Polyclonal anti-NCp9 antisera were produced from New Zealand White rabbits by four injections of 0.5 mg of NCp9 at 2-week intervals (Eurogentec, Seraing, Belgium). The IgG fraction was prepared by chromatography over protein A-agarose (BioRad). Rabbit ␣-Ty3 RT IgG (gift of T. Menees, University of Missouri) was used in a 1:2,000 dilution. Immunoblots were washed with TBST, incubated with secondary antibody, ␣-rabbit IgG horseradish peroxidase (1:25,000), and washed again with TBST. Secondary antibodies to rabbit IgG were detected by chemiluminescence, using the ECL system (Amersham). Immunoblot analysis using rabbit polyclonal ␣-CA, ␣-RT, and ␣-IN was performed as described previously, except that Immobilon-P membranes (Millipore) were used (47) .
Transposition assays. The transposition assay (34) is based on expression of Ty3 under control of the GAL1-10 UAS on a URA3-marked donor plasmid (pEGTy3-1) and subsequent integration of the replicated Ty3 into a HIS3-marked target plasmid (pCH2bo19V). Here, the assay was modified by the addition of a third plasmid, TRP1-marked pHN2068, which provided the VLPs with a source of wild-type CA-IN, TRP-marked pNB2092, which provided CA-RT-IN or pNB2094, which provided CA-RT-IN(cat Ϫ ) in trans, respectively. The target plasmid contains two divergent tRNA genes, sup2bo and tDNA Val (AAC), which recruit Ty3 to the target site. The sup2bo gene is a transcriptionally inactive ochre suppressor tRNA Tyr gene, which is activated by integration of Ty3 into the target site. Transposition is scored by suppression of the ade2-101 lys2-1 ochre nonsense mutations in yeast strain yTM443 yielding papillations on minimal medium supplemented with leucine.
In a qualitative patch assay for Ty3 transposition, independent colonies containing yTM443 cells transformed with pEGTy3-1 or IN-mutant derivatives of the plasmid, the target plasmid pCH2bo19V, and with either pHN2068 (expressing CA-IN) or pHN1889 (vector control) were patched onto SD medium lacking uracil, histidine, and tryptophan to select for all three plasmids. In parallel, cells were transformed with the plasmid pNB2092 (expressing CA-RT-IN) or
Plates were incubated at 30°C for 24 h and replica plated to minimal medium containing leucine (glucose control plates) for negative controls and to SG medium lacking uracil, histidine, and tryptophan to induce Ty3 transposition. After 48 h at 30°C on SG medium, duplicate patches were replica plated onto minimal medium containing leucine and incubated at 30°C for 10 days.
Southern analysis of full-length cDNA. For analysis of nucleic acids in CA-IN trans-complementation assays, 10-ml cultures of yTM443 cells transformed with plasmids expressing wild-type or IN-mutant Ty3 and either pHN2068 or pHN1889 were grown to an A 600 of Ϸ1.0 in SG medium. Cells were pelleted and suspended in 200 l of cell-breaking buffer (1 mM EDTA, 100 mM NaCl, 10 mM Tris [pH 8.0], 1% SDS, 2% Triton X-100) (32) . Nucleic acid was extracted with phenol-chloroform-isoamyl alcohol (25:24:1) while vortexing with glass beads for 5 min at maximum speed and precipitated with ethanol and 0.3 M sodium acetate. The concentration of nucleic acid was measured by A 260 . To detect full-length, replicated DNA in cultures expressing Ty3 mutants and vector or fusion proteins, 10 g of nucleic acid was treated with 1 g of RNase A and digested with 10 U of BamHI. A second Southern blot analysis was performed for cells expressing mutants and the CA-RT-IN fusions. In that experiment 100 g of nucleic acid was used as the starting material. BamHI digestion linearized the expression plasmids (pEGTy3-1 or mutant derivatives, and pHN1889, pHN2068, pNB2092, or pNB2094) and simplified interpretation of the blot. The samples were separated by 0.8% agarose gel electrophoresis. To denature the DNA, the gel was treated sequentially for 15 min each with 0.25 M HCl-0.5 M NaOH, 1 M NaCl-0.5 M Tris [pH 7.5], and 1.5 M NaCl. The DNA was transferred to nitrocellulose (Duralon UV; Stratagene) in 10ϫ SSC with a PosiBlot pressure blotter and immobilized by UV cross-linking. The blot was probed with a Ty3 internal domain-specific probe for 16 h at 65°C in Southern hybridization buffer. The probe was generated by digestion with BglII and labeled with [␣-
32 P]dATP, as described for Northern analysis of Ty3 RNA. A DNA-specific probe (200,000 cpm), produced by digestion with HindIII and labeled with [␣-32 P] dATP, was added to the hybridization reaction mixture to serve as DNA size marker. The blot was washed and exposed to a phosphorimager screen for analysis.
RESULTS
Mutations in Ty3 IN severely affect minus-strand strongstop DNA synthesis in vivo. Previous studies showed that point mutations in the nonconserved amino-and carboxyl-terminal domains of Ty3 IN resulted in reduced amounts of reversetranscribed full-length DNA within the VLP (47) . Exogenous reverse transcriptase assays indicated that DNA polymerase activity, although decreased, was detectable in the mutants, suggesting that Ty3 IN might play a role specific to reverse transcription of the genomic RNA in vivo. To identify the point at which these DNA-deficient IN mutants were affected, Southern blot analysis was used to monitor the levels of replication intermediate species, minus-strand strong-stop DNA (Fig. 1) , which is predicted to be produced early in Ty3 replication. Ty3 transcription is initiated at position 223 of the 340-bp LTR under natural pheromone and GAL1-10 promoter regulation (reference 9 and unpublished observations). Initiation of reverse transcription occurs from a tRNA iMet primer annealed at its 3Ј end to the 5Ј primer-binding site, 2 bp downstream of the U5 region. Thus, a minus-strand, strong-stop DNA would be 118 ϩ 2, i.e., 120 nt in length. Nucleic acid was extracted from sucrose gradient fractions containing wild-type or IN-mutant VLPs and evaluated by Southern analysis with a Ty3-specific probe complementary to minus-strand sequences in the U5 region of the LTR (Fig. 1) . A 120-nt DNA corresponding to the predicted Ty3 minus-strand, strong-stop product was detected in cells expressing wild-type Ty3. Nucleic acid species of other sizes were also present, although at lower amounts. Minus-strand, strong-stop DNA was absent in mutants for which no Ty3 cDNA or very little Ty3 cDNA was detected (mutants 20, 76, 442, 450, and 496) (47) . Mutant 431, which had no measurable RT activity or wild-type RT species, did not exhibit minus-strand, strong-stop DNA in this assay (data not shown) (47) . Mutants with comparable but low levels of Ty3 cDNA (53, 62, 477, 488 , and 499), with the exception of mutant 62, lacked minus-strand, strong-stop DNA. Mutant 62, which had levels of cDNA comparable to the levels of those mutants, had reduced amounts of minus-strand, strong-stop DNA. Of the cDNA-defective mutants, mutant 453 had the highest amount of cDNA and minus-strand, strong-stop DNA. As expected, mutant 419, which is defective in nuclear localization (43) , produced normal levels of full-length DNA and minus-strand, strong-stop DNA. These results argued that a number of mutations act at some early point in reverse transcription but that there are differences in the extent to which each mutation not only acts at some early stage but also influences the efficiency of later steps. IN mutations affect reverse transcription initiation. The deficiencies of mutants in minus-strand, strong-stop DNA suggested a defect early in reverse transcription. To specifically test whether reduced reverse transcription initiation could account for this, a variation of an endogenous RT activity assay, tRNA iMet primer tagging (56), was employed. In the case of Ty3, tRNA iMet is extended with the addition of two guanine nucleotides, followed by thymine. VLPs of wild-type or INmutant Ty3 were incubated with [␣-32 P]dGTP under Ty3 reverse transcription conditions. tRNA iMet extension occurs only if (i) the primer is properly packaged and annealed to the RNA template and (ii) Ty3 RT is active. Thus, tRNA iMet tagging (Fig. 2) measures the efficiency of endogenous reverse transcription initiation. We found that the amounts of dG-and dG-dG-tagged tRNA iMet correlated generally with those of minus-strand, strong-stop DNA observed in mutant VLPs; tagged tRNA iMet was detectable for mutants 62 and 453 and for other mutants with low levels of cDNA, including 53, 477, and 488. The mutants affected in nuclear localization (419 [43] ) and catalysis (IN cat Ϫ , which is a D225E, E261D double mutant [37] ), each of which produces wild-type amounts of Ty3 DNA, provided controls for endogenous reverse transcription activity.
Mutant VLPs contain dimeric Ty3 RNA. The retroviral RNA genome is packaged as a dimer, a process that requires the gag-encoded NC protein (3, 12, 52) . To test whether Ty3 NCp9 processing or stability was affected in the IN mutants, whole-cell extract isolated from cells expressing wild-type or mutant Ty3 was analyzed with antibody to NCp9 (Fig. 3 ). All IN mutants had wild-type levels of GAG3 precursor protein, p38 (38 kDa), and mature NCp9 (9 kDa), indicating that the mutations in IN did not affect NCp9 processing or stability.
To determine if Ty3 VLPs contain a dimeric RNA genome similar to those of retroviruses and whether altered RNA packaging and/or dimerization could account for defective initiation of reverse transcription, RNA was isolated from sucrose gradient fractions enriched for wild-type or IN-mutant VLPs. To test for dimer formation, RNA from wild-type VLPs was incubated at several different temperatures and separated on an agarose gel under conditions similar to those previously described (21, 22) (Fig. 4A) . Both an RNA monomer and a major higher-order species were present in Ty3 VLPs (see RNA at 25 to 35°C) and the higher-order RNA was unstable above 40°C (compare RNAs at 40 and 65°C). As observed for retrovirus dimers (13), the higher-order Ty3 RNA was a diffuse band. All DNA-deficient IN mutants contained RNA that formed a higher-order structure, suggestive of dimerization (Fig. 4B) . Although the amounts of this species were variable and did not correlate well with either the minus-strand, strongstop DNA or cDNA content, each mutant VLP fraction had ratios of complex similar to those observed with a faster-migrating form. These data suggest that the defect in reverse transcription initiation is not due to impaired NCp9 processing or gross defects in Ty3 genomic RNA multimerization.
Mutations in IN affect tRNA iMet packaging into VLPs. To determine whether reduced initiation of Ty3 reverse transcrip- tion initiation reflected defects in tRNA iMet packaging or its inability to act as a substrate for extension, RNA isolated from sucrose gradient fractions containing wild-type or INmutant VLPs was subjected to Northern blot analysis using a tRNA iMet -specific probe (Fig. 5 ). Cells expressing mutants 419 and IN cat Ϫ had cDNA levels similar to those of cells expressing wild-type Ty3 and, as expected, their VLP fraction showed equivalent amounts of tRNA iMet . The nontransformed cell sample contained reduced levels of tRNA iMet compared to the sample from the cells expressing wild-type Ty3. However, the fact that tRNA iMet was present, even in the absence of VLPs, underscored the fact that this is not a highly purified VLP preparation. VLP preparations from cells expressing each DNA-deficient mutant contained lower amounts of tRNA iMet , but with the exception of nuclear localization mutant 419 and mutant 453 (which had greater amounts of cDNA than many other mutants), this remained constant. We next investigated whether the fusion affected transposition via a qualitative version of a plasmid-based suppressor target transposition assay (34) ( Table 3 ). After induction, cells were replica plated to minimal medium containing leucine and transposition was scored as papillations, resulting from suppression of the ochre nonsense markers, ade2-101 lys2-1, in the host strain yTM443. In the absence of the CA-IN protein (Table 3) , all mutants lacked detectable transposition activity (as originally shown) (37, 47) . In the presence of CA-IN (Table  3) , transposition was observed for IN mutants defective in catalytic activity [IN(cat Ϫ )] and nuclear localization (419), indicating that at least a portion of the IN protein expressed as CA-IN could be targeted to VLPs to complement these functions. In contrast, the fusion protein failed to restore transposition to any of the DNA-deficient IN mutants.
It was possible that rescue of DNA synthesis was insufficient to confer detectable transposition activity or that subsequent to this point in the life cycle, replication was defective in the Ty3 IN mutants. For example, mutants in the carboxyl-terminal region of IN (453, 477, and 488) have, in addition to low amounts of cDNA, much lower ratios of 3Ј-processed to unprocessed cDNA than do cells expressing wild-type Ty3 (47) . Two mutants in the amino-terminal region, 53 and 76, had detectable 3Ј end cDNA processing but reduced ratios of processed to unprocessed species relative to the wild-type control. To directly test whether CA-IN might rescue the reverse transcription defect in trans, Southern analysis with a probe to the Ty3 internal domain was used to measure Ty3 cDNA levels in yTM443 cells expressing CA-IN together with wild-type or IN-mutant Ty3 (Fig. 6C ). IN mutants with undetectable or low amounts of full-length replicated Ty3 DNA in the absence of the CA-IN fusion protein (left lane of pair) were unchanged in its presence (right lane of pair), despite prolonged exposure (Fig. 6C) . Thus, CA-IN fusion protein, provided to the VLPs in trans, failed to rescue the transposition or the DNA defect in the IN mutants. . In the protein expressed from these fusions, the region between the amino terminus of NC and the amino terminus of RT was deleted, leaving 5 aa amino terminal to the RT processing site (see Materials and Methods).
Transposition assays in which the Ty3 mutant was expressed together with the vector showed results comparable to those observed previously (Table 3) , was treated with BamHI, separated on a 0.8% agarose gel, and subjected to Southern analysis with a probe specific for the internal (non-LTR) region of Ty3. BamHI was used to linearize the Ty3-containing plasmids, which are detected by the probe. A control sample containing nucleic acid from cells that contained wild-type Ty3 but did not express it because they were grown in SD medium is presented in the leftmost lane. The positions of the expression plasmids and replicated Ty3 DNA (Ty3) are indicated by arrows. Fig.  7a and b, panels A, B , and C; compare second and third lanes). Although some CA-RT-IN fusion was apparent in each transformant ( Fig. 7a and b, panels A, B , and C) and also in transformants expressing CA-RT-IN in the absence of Ty3, the amount of the fusion in cells expressing some Ty3 IN mutants was relatively low, e.g., mutants 442, 453, and 477. Because at least some fusion protein was present in each case and the pattern was the same for wild-type and cat Ϫ mutant fusion proteins (with the possible exception of mutant 53), it seemed likely that this difference in amount of fusion protein reflected differential stability in the presence of individual Ty3 mutants rather than differential expression of the fusion protein in different transformants. Thus, differences in the abilities of the two constructs to complement transposition could not be ascribed to gross differential stability of the two fusion proteins in target cells. These results also suggested that, at least in some cases, the fusion proteins interacted with proteins expressed in trans from the intact Ty3 element. Inspection of the patterns visualized with antibodies against IN and RT indicated that overall they were similar to those observed originally for the mutants and here in the presence of vector plasmid (47) (Fig.  7a and b , panels A to C, leftmost lanes compared to right two lanes). Only in the case of mutant 450 did cells expressing the fusion contain more mature IN. Likewise, mutant 442 contained slightly more mature RT in cells expressing the fusion, suggesting that for some mutants, the fusion was incorporated into the particle and partial processing occurred.
In order to directly assess the effect of CA-RT-IN expression in trans upon Ty3 cDNA synthesis, Southern blot analysis was performed with a Ty3-specific probe (Fig. 7a and b, panels D) . Originally the same amounts of cellular DNA analyzed were similar to that of cells expressing the CA-IN fusion (data not shown). Because this analysis suggested an effect of expressing the fusion protein, the experiment was repeated using 10 times the original amount of total cellular DNA. For this experiment, the amount of DNA from wild-type cells was decreased to one-fifth of the amount loaded for mutant cells. Full-length Ty3 cDNA was detected in cells expressing wild-type Ty3 in the presence or absence of pHN1889 vector. The amount of cDNA slightly increased in cells expressing the CA-RT-IN fusion protein ( Fig. 7a and b , wt [wild-type] lanes). Cells expressing the nuclear localization mutant had the greatest Ty3 cDNA content, and this did not appear to be affected by trans expression of the fusion protein. The cDNA was barely detectable in mutants 62, 453, and 488 ( Fig. 7a and b, panels D) .
DISCUSSION
Mutations in Ty3 IN cause pleiotropic defects in the retroelement life cycle. In previous studies, it was shown that these mutations can destabilize IN and RT, reduce the amount of cDNA associated with VLPs, interfere with 3Ј-end processing of the cDNA, and affect nuclear targeting by IN (26, 37, 43, 47) . Here we investigated mutations that reduce cDNA levels in order to better understand the role of the IN domain in replication. The results showed that IN is essential even for early stages of reverse transcription, supporting a model where the IN and RT domains act in close association, with IN potentially a component of a heterodimeric RT.
IN mutations cause defects in Ty3 reverse transcription prior to appearance of minus-strand, strong-stop DNA. In order to determine the point at which a reduction in Ty3 cDNA was first apparent, we monitored cDNA synthesis substrates and intermediates predicted to exist based on the retrovirus replication model. In this study the predicted 120-nt minus-strand, strong-stop DNA was identified for the first time in VLPs from cells expressing wild-type Ty3. Southern analysis was used to determine minus-strand, strong-stop DNA levels in 12 IN mutants deficient for cDNA (47) . For each mutant this correlated roughly with the amounts of full-length, replicated extrachromosomal Ty3 cDNA, arguing against a model where IN reduces stability of a mature cDNA and suggesting that the mutations might disrupt early steps of replication. The on November 10, 2017 by guest http://jvi.asm.org/ earliest step at which endogenous RT activity can be measured is extension of the tRNA primer in the presence of exogenous deoxynucleoside triphosphates. This activity was significantly decreased in most mutants. The tRNA iMet primer levels were also reduced in mutant VLPs, although interpretation of these data was complicated by significant tRNA iMet in the equivalent fraction of cells not expressing Ty3. Together these results suggested that IN is part of the reverse transcription initiation complex, acting to facilitate RT folding or modulate RNaseH activity, or even as part of a heterodimeric RT.
The apparent failure of Ty3 tRNA iMet primer to concentrate in the mutant VLPs has multiple implications for reverse transcription initiation complex formation. In the case of retroviruses, RNA dimerizes during assembly. There is evidence in the case of Ty1, a copialike element from S. cerevisiae (19) , and Tf1, a gypsylike element from Schizosaccharomyces pombe (28) , of multimeric RNA genomes. In vitro studies have suggested a model in which Ty3 RNAs dimerize through an initiator tRNA iMet primer dimer linkage (23) . In order to address whether reduced tRNA iMet interferes with genomic RNA multimerization, Northern analysis was used to characterize genomic RNA in the mutant VLPs. All mutants contained RNA that was present as a monomer and a single higher-order species, suggesting that, even in severely disrupted mutants, formation of Ty3 RNA complexes was unaffected,. Therefore, it seems likely that there may be interactions in vivo in addition to tRNA iMet that stabilize any essential genomic RNA complex and that the major defect in reverse transcription occurs subsequent to formation of any genomic complexes required for replication.
Mutations in Ty3 IN that cause loss of early intermediates do so through different combinations of mutant effects. Our findings showed that the IN domain is required early in reverse transcription; nevertheless, it seemed unlikely that such mutations so widely distributed in the secondary structure could act in exactly the same way to affect IN activity. Comparison of the molecular phenotypes supports the conclusion that there are molecular differences among these mutants. The presence of a significant amount of tRNA iMet in the VLP fraction of cells not expressing Ty3 precluded a definitive correlation between the levels of tRNA primer packaged and minus-strand, strong-stop DNA. Ty3 mutants 419 (NLS Ϫ ) and 453, which had the highest cDNA content, showed the greatest amount of primer tRNA in the VLP fraction. However, other mutants, which had low amounts of cDNA, were similar to each other, to mutants with no detectable cDNA, and to the nontransformed control in their primer content. Thus, either the background amount of primer obscured differences or factors other than tRNA primer incorporation contributed to extreme defects in cDNA amounts observed in some mutants. Activity in the primer extension assay and the amount of minus-strand, strong-stop DNA were reduced in all 12 mutants, but the extent of this reduction did not correlate absolutely with the amount of fulllength cDNA. For example, mutants 53, 62, 477, and 488 had similar low amounts of full-length cDNA. Primer extension products were readily apparent for all those mutants. However, only mutant 62 also displayed readily detectable minus-strand, strong-stop DNA. These results indicated that, in spite of the commonality of the cDNA deficit, either these IN mutations do not act in exactly the same way or their effects on reverse transcription do not reach the same extent.
The trans complementation of Ty3 cDNA defects supports a role for a Ty3 RT-IN fusion protein in cDNA production. Studies with HIV-1 IN mutations affecting DNA synthesis have shown that alterations to conserved residues including the amino-terminal zinc-binding domain and the carboxyl-terminal F185 and K186 residues affect minus-strand, strong-stop DNA synthesis (17, 18, 45, 58) . However, the effects of these mutations are not understood mechanistically. Rescue of the Ty3 IN mutant cDNA defects was weak, in spite of the fact that the fusion was expressed from the same strong promoter as Ty3 and is, moreover, not attenuated by frameshifting. There are several possible explanations for weakness of the rescue. In studies of HIV-1 IN mutants with reduced cDNA, Vpr-IN and Vpr-RT-IN expressed in trans complemented IN mutants. As noted above, failure of processing of CA from IN or RT-IN could have interfered with activity. A second explanation for the weak complementation activity is that the fusion was inefficiently incorporated into VLPs. In the case of Ty3, CA was the sole module known to have particletargeting activity. Not surprisingly, preparations of VLP fractions from cells expressing CA-RT-IN had comparable amounts of fusion proteins in the particle fraction in the presence and absence of wild-type Ty3 expression (data not shown). As noted above, the facts that (i) the stability of the fusion protein differs depending upon the mutant that is coexpressed and (ii) CA-IN and CA-RT-IN fusions complement NLS and catalytic mutants demonstrate that some fusion protein associates with wild-type Ty3 VLPs. Nevertheless, fusion protein particle formation could compete with VLP formation. The fact that rescue, particularly of the cDNA phenotype, was observed with CA-RT-IN but not CA-IN is intriguing and supports a model where RT and IN domains function closely or even in cis in Ty3 replication. Unfortunately, these experiments do not render a final determination of whether or not the physiologically relevant Ty3 reverse transcriptase is actually a heterodimeric protein.
Integration and polymerase functions of Ty3 IN are independent. The CA-RT-IN(cat Ϫ ) fusion was expressed together with the IN mutants in order to determine whether the IN domains contributing to reverse transcription and integration are separable. No major differences in cDNA production between the effects of the IN(cat Ϫ ) fusion and the wild-type fusion were observed, supporting a model in which these functions are separate. This is also observed for HIV-1 IN mutants with cDNA deficiency (58) . Surprisingly, only Ty3 cDNA mutant 62 was complemented by the CA-RT-IN(cat Ϫ ) fusion. In particular, mutant 76, which had amounts of IN and cDNA comparable to those of mutant 62, was not complemented. Previous analysis of cDNA 3Ј-end processing by these mutants suggests an explanation for this apparent discrepancy. Mutant 76 and several others showed reduced ratios of 3Ј-end processed to unprocessed cDNA. One possible explanation of the failure of the CA-RT-IN(cat Ϫ ) fusion to complement mutant 76 is that neither the fusion nor mutant IN is fully catalytically active. In the case of other mutants with reduced ratios of 3Ј-processed cDNA (453, 477, 488, and 496) and some reduction in IN protein, it is less clear whether the reduced ratios indicate a catalytic defect.
Integration functions of Ty3 IN act in cis with portions of the IN carboxyl-terminal domain. One unexpected result to emerge from expression of the CA-RT-IN(cat Ϫ ) fusion was its failure to complement the NLS mutant. Controls indicated that failure was not attributable to lack of expression. The NLS motif in Ty3 is located in the carboxyl-terminal region of IN, similar to its location in HIV-1 (4) and avian sarcoma virus IN (38) . In vitro studies of HIV-1 IN identified a domain carboxyl terminal to the central conserved domain required in cis to the catalytic site for strand transfer (16) . The HIV-1 IN NLS was subsequently mapped within this domain. Nevertheless, NLS mutants have been reported to complement integration of catalytic site mutants when expressed in trans as Vpr fusions (4) . In the case of HIV-1, NLS mutant recombinant IN has disintegration activity, but the NLS mutant virus cannot infect dividing cells (24) , which are not expected to require NLS function per se. NLS mutants of avian sarcoma virus are also defective at a late step for infection of dividing cells (38) . Although mutations in the Ty3 NLS do not block 3Ј-end processing, they block in vitro integration mediated by the VLP fraction (43) . If residues in the Ty3 NLS necessary for integration are required to act in cis with the catalytic site, it would explain why the CA-RT-IN(cat Ϫ ) fusion fails to complement the Ty3 NLS mutant in trans.
The experiments described here demonstrate that the Ty3 IN domain plays a central and early role in reverse transcription in vivo. Mutations in the nonconserved amino-and carboxyl-terminal domains disrupt events just prior to or at reverse transcription initiation and may even affect incorporation of the primer into the initiation complex. Although CA-IN delivered in trans complemented nuclear localization and integration functions, only CA-RT-IN rescued any mutants with severe defects in cDNA synthesis. These findings argue that Ty3 IN and RT domains associate to facilitate initiation of reverse transcription.
